Seaport Res Ptn Predicts Reduced Earnings for Aspen Aerogels

Aspen Aerogels, Inc. (NYSE:ASPNFree Report) – Seaport Res Ptn lowered their FY2024 earnings estimates for Aspen Aerogels in a report issued on Monday, November 11th. Seaport Res Ptn analyst T. Curran now forecasts that the construction company will post earnings of $0.11 per share for the year, down from their previous estimate of $0.19. The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.11 per share. Seaport Res Ptn also issued estimates for Aspen Aerogels’ Q4 2024 earnings at $0.09 EPS, Q1 2025 earnings at $0.06 EPS, Q2 2025 earnings at $0.16 EPS, Q3 2025 earnings at $0.19 EPS, Q4 2025 earnings at $0.19 EPS, FY2025 earnings at $0.60 EPS and FY2026 earnings at $0.83 EPS.

ASPN has been the subject of several other research reports. Benchmark restated a “buy” rating and set a $14.00 price target on shares of Aspen Aerogels in a report on Thursday, August 8th. StockNews.com upgraded Aspen Aerogels to a “sell” rating in a report on Wednesday. HC Wainwright reiterated a “buy” rating and issued a $30.00 target price on shares of Aspen Aerogels in a research note on Wednesday, October 16th. Roth Mkm lowered their target price on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a research note on Friday, November 8th. Finally, Piper Sandler decreased their price objective on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a report on Tuesday, October 22nd. One equities research analyst has rated the stock with a sell rating, nine have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $28.70.

View Our Latest Research Report on Aspen Aerogels

Aspen Aerogels Stock Down 1.6 %

Shares of ASPN stock opened at $15.54 on Thursday. The stock has a market cap of $1.28 billion, a P/E ratio of 1,555.56 and a beta of 2.21. The company’s fifty day simple moving average is $22.66 and its two-hundred day simple moving average is $24.74. The company has a quick ratio of 2.82, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. Aspen Aerogels has a 52 week low of $9.57 and a 52 week high of $33.15.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. BNP Paribas Financial Markets grew its stake in Aspen Aerogels by 85.2% in the 1st quarter. BNP Paribas Financial Markets now owns 25,706 shares of the construction company’s stock valued at $452,000 after acquiring an additional 11,823 shares during the last quarter. Oppenheimer & Co. Inc. acquired a new position in shares of Aspen Aerogels during the 1st quarter worth approximately $388,000. Swiss National Bank lifted its stake in Aspen Aerogels by 16.2% in the 1st quarter. Swiss National Bank now owns 120,500 shares of the construction company’s stock valued at $2,121,000 after buying an additional 16,800 shares in the last quarter. Vanguard Group Inc. grew its holdings in Aspen Aerogels by 5.1% during the 1st quarter. Vanguard Group Inc. now owns 3,619,702 shares of the construction company’s stock valued at $63,707,000 after buying an additional 175,906 shares during the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund purchased a new position in Aspen Aerogels during the first quarter worth $851,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Aspen Aerogels

In related news, CFO Ricardo C. Rodriguez sold 32,465 shares of the business’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $30.14, for a total transaction of $978,495.10. Following the completion of the sale, the chief financial officer now owns 20,790 shares in the company, valued at $626,610.60. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In related news, CEO Donald R. Young sold 63,355 shares of the company’s stock in a transaction on Monday, September 30th. The stock was sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the transaction, the chief executive officer now owns 483,640 shares of the company’s stock, valued at $14,523,709.20. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Ricardo C. Rodriguez sold 32,465 shares of the business’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $30.14, for a total transaction of $978,495.10. Following the sale, the chief financial officer now owns 20,790 shares in the company, valued at $626,610.60. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.30% of the stock is owned by insiders.

About Aspen Aerogels

(Get Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Featured Articles

Earnings History and Estimates for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.